Shows
EyeluminariesEyes on Washington: How the latest news is affecting eye careIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in t...
2025-04-2241 min
EyeluminariesLive from AAO Eyecelerator 2024: Humanitarian work in eye careIn this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, are live from Eyecelerator with Mend the Gap hosts Susan MacDonald, MD, and Cathleen McCabe, MD, discussing their humanitarian work. Welcome to the Eyeluminaries podcast :02 In this episode :31 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 1:00 What started you on this journey to do humanitarian work? 2:18 MacDonald discusses the role of parents in defining of happiness. 7:47 Hovanesian discusses the background of his humanitarian work in Armenia. 8:24 What about the funding of these humanitarian projects? 9:38 What are your stories from doing humanitarian work? 10:59 What advice to do you h...
2024-11-2630 min
EyeluminariesThe Latest News and Notes, plus Conversation with Tom MitroIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 26 :58 FDA grants fast track designation to brepocitinib for noninfectious uveitis 1:42 I. Howard Fine, MD, esteemed ophthalmologist, dies 3:54 First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia 5:48 LENZ Therapeutics submits NDA for drops to treat presbyopia 7:57 Intro of Tom Mitro 10:40 Tell us about your journey in ophthalmology 12:38 Tell us about the new dry eye drug from Signal 12. 15:53 How much s...
2024-10-3034 min
EyeluminariesThe Latest News and Notes, plus Conversation with Cathleen McCabe, MDIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Cathleen McCabe, MD, about the ASCRS Foundation and role models in ophthalmology; plus, the latest news in eye care. • Welcome to the Eyeluminaries podcast :05 • Review of episode 25 :46 • Bausch + Lomb acquires Trukera Medical 1:32 • CMS proposes cutting physician payments for fifth straight year 4:09 • FDA clears Alcon’s Unity cataract system, Unity vitreoretinal cataract system 7:40 • FDA approves Eylea biosimilar FYB203/Ahzantive 11:07 • Intro of Cathleen McCabe, MD 13:07 • American Society of Cataract and Refractive Surgery (ASCRS) has become an important organization to advocate, educate and organize docto...
2024-07-3135 min
EyeluminariesThe Latest News and Notes, plus Conversation with Jack Holladay, MD, MSEEIn this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss leadership in eye care with guest Jack T. Holladay, MD, MSEE, FACS. Brought to you by Johns Hopkins University. • Welcome to the Eyeluminaries podcast :21 • Review of episode 23 1:19 • Blog by John A. Hovanesian, MD, FACS 3:10 • Merck to acquire EyeBio 4:14 • FDA approves aflibercept biosimilars Yesafili, Opuviz 6:26 • Aurion Biotech completes enrollment in phase 1/2 corneal edema cell therapy trial 8:43 • Intro of Jack Holladay, MD, MSEE 11:10 • How did you develop a passion for optics? Did you know it was going to be your future? 13:50
2024-06-1932 min
Outcomes RocketMedical Device Playbook Conference Invitation with Scott Phillips, CEO and Founder of StarFish MedicalJoin 250 Medtech entrepreneurs, start-ups, and entrepreneurial organizations from across North America.Register now for a full day of medical device commercialization information and inspiration.STANTON J. ROWEFounder & CEO, NXT Biomedical Incubator - Former Chief Scientific Officer and Corporate Vice President of Advanced Technology of Edwards Lifesciences Corp.PAUL LOVOI, PH.D.Co-Founder and CTO, MindRhythm Inc. - Serial entrepreneur of eight companiesDEEPIKA A. LAKHANI PH.D.Vice President of Regulatory & Quality, PAVmed Inc...
2023-04-1407 min
EyeluminariesThe Latest News and Notes, live from Hawaiian EyeHosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest news stories, live from Hawaiian Eye. Welcome to the Eyeluminaries podcast :01 Review of episode 10, the Allergan alumni guests 1:30 Bausch + Lomb announces acquisition of AcuFocus 3:39 Mazzo attributes success to people and the magic of ophthalmology 5:40 Keranova’s PhotoEmulsification technique shows promising results 9:25 Centricity CEO discusses latest cataract surgery products 11:04 Orasis submits new drug application for presbyopia drop 12:30 Aldeyra submits NDA for primary vitreoretinal lymphoma treatment 15:27 Iveric Bio submits final part of Zimura new drug application for rolling review 17:30 Tom Frinzi to become CEO of STAAR Surgical 22:37 Wrap up...
2023-02-0128 min
EyeluminariesThe Latest News and Notes, plus Conversation with David W. Parke II, MDIn this episode, David W. Parke II, MD, sits down with hosts, Jim Mazzo and John A. Hovanesian, MD, FACS, to discuss stepping down as the American Academy of Ophthalmology CEO, the highlights of what he accomplished during this time, and his thoughts on the future of ophthalmology. Welcome to the Eyeluminaries podcast :10 News and notes with John and Jim 1:30 Allergan’s Vuity presbyopia-correcting drop gains FDA approval 1:36 Glaukos’ two phase 2 clinical trials for dry eye disease and presbyopia 3:30 Acufocus’ receives “approvable” letter on IC-8 IOL 5:42 Harrow Health acquires four ophthalmic drugs from Novartis 8:40 Welcome David Parke 10:54 What’s it like ha...
2022-02-0241 min
OIS Podcast | Ophthalmology's leading PodcastNever Take No For An AnswerThis week Dr Sadri is joined by Ram Rao, CEO of LensGen, who developed a curvature changing fluid lens to correct presbyopia. Ram tells his story from the early beginning while collaborating with the late, great Roger Steinert, MD and realizing that they had to go back to the drawing board to reinvent the technology. Rather than throw in the towel after hearing no repetitively from investors, Ram persevered at all costs, subsequently raised $42M to date and emerged with a breakthrough technology to treat cataracts and presbyopia. Listen in for pearls of entrepreneurial wisdom and understand why Ram n...
2020-09-0230 min
DeviceAlliance: MedTech RadioRam Rao: Vision with Purpose | Ep.20LensGen is a clinical stage company headquartered in Irvine, California focused on restoring youthful vision to millions of cataract and presbyopia patients. With its innovative Juvene™ modular fluid optic intraocular lens the company aims to treat vision correction errors and provide spectacle independence to patients affected by cataracts and/or presbyopia. Their leader is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. What are some of the key strategic insights to scaling a startup to a large scale medtech organization? In this episode of DeviceAlliance’s Medtech Radio, we speak with the CEO...
2020-03-0233 min
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, AnywhereRamgopal P. Rao, CEO at LensGen, Inc.Send us a textRam is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry. Ramgopal is Inventor, Founder, and Chief Executive Officer of LensGen, Inc., a clinical-stage medical device company that is developing a novel intraocular lens for presbyopia. The Company has received support from one of the largest medical device companies in the world, and this led to LensGen closing a $28.0 million Series A Financing in May 2018.Currently, he is also Chairman of the Board of 2C Tech Corporation, Inc., an emerging medical device company that is developing...
2019-11-2322 min
OIS Podcast | Ophthalmology's leading PodcastCEO Ram Rao Discusses Juvene, the Rise of Presbyopia, and How LensGen Raised $21 millionLensGen CEO Ram Rao discusses his company’s $21 million Series A and the increased interest in presbyopia.
2017-05-1011 min